GENERAL ATLANTIC, L.P.
CIK: 1017645
Holdings (12)
Q2 2026 13F, quarter ended Jun 30, 2026, filed Aug 14, 2026
- LFTO
LIFTOFF MOBILE
$608.08M
25.32M sh20.92%New - DLO
DLOCAL
$606.3M
46.66M sh20.86%+0.0% - CHYM
CHIME
$435.4M
21.26M sh14.98%+0.0% - ALKT
ALKAMI
$351.15M
19.38M sh12.08%+26.4% - XP
XP, INC
$334.41M
20.57M sh11.50%+0.0% - PHVS
PHARVARIS
$226.53M
6.55M sh7.79%-18.4% - SPTX
SEAPORT THERAPEUTICS
$132.53M
6.10M sh4.56%New - NRIX
NURIX THERAPEUTICS
$73.56M
3.03M sh2.53%-26.1% - RVMD
REVOLUTION MEDICINES
$67.01M
357,791 sh2.31%-49.5% - PBLS
PARABILIS MEDICINES
$42.11M
1.54M sh1.45%New - RSKD
RISKIFIED
$26.84M
5.32M sh0.92%+0.0% - GROV
GROVE COLLABORATIVE
$3.09M
2.47M sh0.11%+0.0%
| Security | Shares | Value | Change | Weight | Period |
|---|---|---|---|---|---|
 LFTO LIFTOFF MOBILE | 25.32M | $608.08M | New | 20.92% | Q2 2026 |
 DLO DLOCAL | 46.66M | $606.3M | +0.0% | 20.86% | Q2 2026 |
 CHYM CHIME | 21.26M | $435.4M | +0.0% | 14.98% | Q2 2026 |
 ALKT ALKAMI | 19.38M | $351.15M | +26.4% | 12.08% | Q2 2026 |
 XP XP, INC | 20.57M | $334.41M | +0.0% | 11.50% | Q2 2026 |
 PHVS PHARVARIS | 6.55M | $226.53M | -18.4% | 7.79% | Q2 2026 |
 SPTX SEAPORT THERAPEUTICS | 6.10M | $132.53M | New | 4.56% | Q2 2026 |
 NRIX NURIX THERAPEUTICS | 3.03M | $73.56M | -26.1% | 2.53% | Q2 2026 |
 RVMD REVOLUTION MEDICINES | 357,791 | $67.01M | -49.5% | 2.31% | Q2 2026 |
 PBLS PARABILIS MEDICINES | 1.54M | $42.11M | New | 1.45% | Q2 2026 |
 RSKD RISKIFIED | 5.32M | $26.84M | +0.0% | 0.92% | Q2 2026 |
 GROV GROVE COLLABORATIVE | 2.47M | $3.09M | +0.0% | 0.11% | Q2 2026 |
1-12 of 12 holdings
Sector Allocation
SEC Filings
| Form | Description | Filed |
|---|---|---|
About GENERAL ATLANTIC, L.P.
GENERAL ATLANTIC, L.P. is an Investment Adviser that reports its US-listed stock and option positions to the SEC on Form 13F (CIK 1017645). Signal8 holds 20 13F filings from it. Its SEC filings list Delaware as its state of incorporation.
Its most recent 13F holdings report covers Q2 2026 (the quarter ended Jun 30, 2026) and was filed on Aug 14, 2026. That report lists 12 securities, not counting options, the same number as in Q1 2026.
Its five largest reported positions, in order, are LIFTOFF MOBILE (LFTO), DLOCAL (DLO), CHIME (CHYM), ALKAMI (ALKT) and XP, INC (XP). The next five are PHARVARIS (PHVS), SEAPORT THERAPEUTICS (SPTX), NURIX THERAPEUTICS (NRIX), REVOLUTION MEDICINES (RVMD) and PARABILIS MEDICINES (PBLS).
Recent 13F filings by GENERAL ATLANTIC, L.P.
- Q2 2026: 13F-HR filed Aug 14, 2026, listing 12 securities.
- Q1 2026: 13F-HR filed May 15, 2026, listing 12 securities.
- Q4 2025: 13F-HR filed Feb 17, 2026, listing 13 securities.
- Q3 2025: 13F-HR filed Nov 13, 2025, listing 16 securities.
- Q2 2025: 13F-HR filed Aug 14, 2025, listing 15 securities.
- Q1 2025: 13F-HR filed May 14, 2025, listing 15 securities.